Preston Klassen

Affiliations

  • President & Head Of R & D at Regulus Therapeutics Inc. (RGLS), 2025-06-04
  • Director at Metacrine Inc. (MTCR), 2023-03-24
  • President And Coo at Zura Bio Ltd (ZURA), 2023-03-21
  • Evp And Cmo at Arena Pharmaceuticals Inc (ARNA), 2020-03-03
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2019-07-01
  • Evp, Global Development at Orexigen Therapeutics Inc. (OREX), 2016-02-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RGLS $7.99 12,000 $95,852.40 48,055 2025-06-03 Filing
MTCR $3.64 20,547 $74,692.45 20,547 2021-05-20 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RGLS $1.26 31,445 $39,721.32 36,055 2025-01-13 Filing
MTCR $0.41 380,605 $157,265.99 541,905 2023-01-26 Filing
MTCR $0.51 1,173 $593.07 922,510 2022-04-19 Filing
MTCR $0.50 43,575 $21,879.01 923,683 2022-04-19 Filing
ARNA $44.00 3,000 $132,000.00 0 2019-01-08 Filing